New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting

CCO Oncology Podcast

内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容（包括剧集、图形和播客描述）均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

1+ y ago 21:46

MP3•单集首页

In this episode, Christopher R. Flowers, MD, MS, and Kami Maddocks, MD, discuss their choices of recent important trials presented at the Society of Hematologic Oncology 2022 Annual Meeting evaluating the use of BTK inhibitors in chronic lymphocytic leukemia and mantle cell lymphoma. The discussion includes analyses of:

GLOW: phase III randomized trial of ibrutinib plus venetoclax vs chlorambucil plus obinutuzumab for older or unfit patients with previously untreated chronic lymphocytic leukemia
BRUIN: phase I/II study of pirtobrutinib for previously treated mantle cell lymphoma (including previous BTK inhibitor)

Presenters:

Christopher R. Flowers, MD, MS
Department Chair, Department of Lymphoma/Myeloma
Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Kami Maddocks, MD
Professor of Clinical Internal Medicine
Division of Internal Medicine
Department of Hematology
The Ohio State University
Lymphoma Program Director
The Ohio State University James Cancer Hospital
Columbus, Ohio

168集单集

#Science #Fitness #Biology #Higher Education #Podcasting Education #Medicine #Clinical Care Options, LLC #Clinical Care Options #Essential Thrombocythemia #Myelofibrosis #Oncology #CME #Nonmalignant Hematological Disorders #Skin Cancer #Hematological Malignancies #Acute Myeloid Leukemia #Kidney Cancer #Melanoma #Gastrointestinal Cancer #Acute Lymphocytic Leukemia #Prostate Cancer #Myeloproliferative Neoplasms #Follicular Lymphoma #Glioblastoma #Nsclc #Multiple Myeloma #Hodgkin Lymphoma #Basal Cell Carcinoma #All #Polycythemia Vera #Breast Cancer #Dlbcl #Head And Neck Cancer #Liver Cancer #Sarcoma #Gastroesophageal Cancer #Lung Cancer #Hepatocellular Carcinoma #Urothelial Carcinoma #Cancer Screening #Renal Cell Carcinoma #AML #Ovarian Cancer #CPE #Lymphoma #Diffuse Large B-cell Lymphoma #Cll #Pancreatic Cancer #Beta-thalassemia #Chronic Myeloid Leukemia